Cubist Systematic Strategies, LLC Moderna, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 55,802 shares of MRNA stock, worth $1.73 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
55,802
Previous 315,800
82.33%
Holding current value
$1.73 Million
Previous $21.1 Million
89.01%
% of portfolio
0.02%
Previous 0.13%
Shares
16 transactions
Others Institutions Holding MRNA
# of Institutions
923Shares Held
255MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.25 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.21 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$795 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$546 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$227 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...